The microbiota in inflammatory bowel disease: Friend, bystander, and sometime-villain

Nutrition Reviews

Volumn 70, Issue SUPPL. 1, 2012, Pages

  Shanahan, Fergus ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Crohn's disease; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; G PROTEIN COUPLED RECEPTOR; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR;

ARTICLE; BIODIVERSITY; CROHN DISEASE; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENETIC RISK; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HUMAN; IMMUNITY; INNATE IMMUNITY; INTESTINE FLORA; LIFESTYLE MODIFICATION; SMOKING; ULCERATIVE COLITIS;

DIET; DISEASE SUSCEPTIBILITY; GENETIC PREDISPOSITION TO DISEASE; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATORY BOWEL DISEASES; METAGENOME; RISK FACTORS;

EID: 84864756966     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2012.00502.x     Document Type: Article

References (71)

1. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573-621.
2. Clemente JC, Ursell LK, Parfrey LW, etal. The impact of the gut microbiota on human health: an integrative view. Cell. 2012;148:1258-1270.
3. Hill DA, Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol. 2010;28:623-667.
4. Sartor RB. Microbial influences in inflammatory bowel disease. Gastroenterology. 2008;134:577-594.
5. Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology. 2011;140:1729-1737.
6. Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011;140:1720-1728.
7. Henderson P, Satsangi J. Genes in inflammatory bowel disease: lessons from complex diseases. Clin Med. 2011;11:8-10.
8. Stappenbeck TS, Rioux JD, Mizoguchi A, etal. Crohn disease. A current perspective on genetics, autophagy and immunity. Autophagy. 2011;7:355-374.
9. Barrett JC, Lee JC, Lees CW, etal. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet. 2009;41:1330-1334.
10. Cooney R, Baker J, Brain O, etal. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med. 2010;16:90-97.
11. Travassos LH, Carneiro LA, Ramjeet M, etal. Nod1 and Nod 2 direct authophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. 2010;11:55-62.
12. Melgar S, Shanahan F. Inflammatory bowel disease - from mechanisms to treatment strategies. Autoimmunity. 2010;43:1-15.
13. Glocker E-O, Kotlarz D, Boztug K, etal. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361:2033-2045.
14. Tysk C, Lindberg E, Jarnerot G, etal. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut. 1988;29:990-996.
15. Sartor RB. Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis. Gastroenterology. 2010;139:1816-1833.
16. Turnbaugh PJ, Hamady M, Yatsunenko T, etal. A core gut microbiome in obese and lean twins. Nature. 2009;457:480-484.
17. Willing BP, Dicksved J, Halfarson J, etal. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010;139:1844-1854.
18. Bernstein CN, Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut. 2008;57:1185-1191.
19. Biedermann L, Zeitz J, Sutter-Minder E, etal. Smoking cessation leads to profound changes in the composition of the intestinal microbiota - a controlled prospective interventional study using terminal restriction fragment length polymorphism and pyrosequencing. In: Program and abstracts of Digestive Disease Week 2011; 7-11 May 2011; Chicago. Abstract 858.
20. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9:313-323.
21. Sekirov I, Rusell SL, Antunes LCM, etal. Gut microbiota in health and disease. Physiol Rev. 2010;90:859-904.
22. Garrett WS, Gordon JI, Glimcher LH. Homeostasis and inflammation in the intestine. Cell. 2010;140:859-870.
23. Blaser MJ, Falkow S. What are the consequences of the disappearing microbiota? Nat Rev Microbiol. 2009;7:887-894.
24. Fumagalli M, Pozzoli U, Cagliani R, etal. Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. J Exp Med. 2009;206:1395-1408.
25. Shoda R, Matsueda K, Yamato S, etal. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr. 1996;63:741-745.
26. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, etal. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology. 2009;137:1716-1724.
27. Murphy EF, Cotter PD, Healy S, etal. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut. 2010;59:1635-1642.
28. De Filippo C, Cavalieri D, Di Paola M, etal. Impact of diet in shaping gut microbiota revealed by comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA. 2010;107:14691-14696.
29. Shanahan F, Murphy E. The hybrid science of diet, microbes and metabolic health. Am J Clin Nutr. 2011;94:1-2.
30. Muegge BD, Kuczynski J, Knights D, etal. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science. 2011;332:970-974.
31. Faith JJ, McNulty NP, Rey FE, etal. Predicting a human gut microbiota's response to diet in gnotobiotic mice. Science. 2011;333:101-104.
32. Hviid A, Svanström H, Frisch M. Antibiotic use in inflammatory bowel diseases in childhood. Gut. 2011;60:49-54.
33. Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol. 2010;105:2687-2692.
34. Lorber B. Are all diseases infectious? Ann Intern Med. 1996;125:844-851.
35. Lebeer S, Vanderleyden J, De Keersmaecker SCJ. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol. 2010;8:171-184.
36. Round JL, Lee SM, Li J, etal. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science. 2011;332:974-977.
37. Cadwell K, Patel KK, Maloney NS, etal. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell. 2010;141:1135-1145.
38. Qin J, Li R, Raes J, etal. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59-65.
39. Swidsinski A, Ladhoff A, Pernthaler A, etal. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122:44-54.
40. Abubakar I, Myhill D, Aliyu SH, etal. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm Bowel Dis. 2008;14:401-410.
41. Darfeuille-Michaud A, Boudeau J, Bulois P, etal. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004;127:412-421.
42. Clayton EM, Rea MC, Shanahan F, etal. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol. 2009;104:1162-1169.
43. Peterson DA, Frank DN, Pace NR, etal. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe. 2008;3:417-427.
44. Sokol H, Pigneur B, Watterlot L, etal. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA. 2008;105:16731-16736.
45. Schwiertz A, Jacobi M, Frick J-S, etal. Microbiota in pediatric inflammatory bowel disease. J Pediatr 2010;157:240-244.e1.
46. Frank DN, St. Amand AL, Feldman RA, etal. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA. 2007;104:13780-13785.
47. Pruteanu M, Hyland NP, Clarke DJ, etal. Degradation of the extracellular matrix components by bacterial-derived metalloproteases: implications for inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17:1189-1200.
48. Knight P, Campbell BJ, Rhodes JM. Host-bacteria interaction in inflammatory bowel disease. Br Med Bull. 2008;88:95-113.
49. Sewell GW, Marks DJB, Segal AW. The immunopathogenesis of Crohn's disease: a three-stage model. Curr Opin Immunol. 2009;21:506-513.
50. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008;453:620-625.
51. H17 cell differentiation. Nature. 2008;455:808-812.
52. MacDonald TT, Monteleone I, Fantini MC, etal. Regulation of homeostasis and inflammation in the intestine. Gastroenterology. 2011;140:1768-1775.
53. Maslowski KM, Vieira AT, Ng A, etal. Regulation of immunomodulatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461:1282-1286.
54. Fukuda S, Toh H, Hase K, etal. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469:543-547.
55. Suzuki K, Meek B, Doi Y, etal. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc Natl Acad Sci USA. 2004;101:1981-1986.
56. Wen L, Ley RE, Volchkov PV, etal. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature. 2008;455:1109-1113.
57. Vijay-Kumar M, Aitken JD, Carvalho FA, etal. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010;328:228-231.
58. Garrett WS, Lord GM, Punit S, etal. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell. 2007;131:33-45.
59. Garrett WS, Gallini CA, Yatsunenko T, etal. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Gell Host Microbe. 2010;8:292-300.
60. Bloom SM, Bijanki VN, Nava GM, etal. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe. 2011;9:390-403.
61. Elinav E, Strowig T, Kau AL, etal. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011;145:1-13.
62. Van Lookeren Campagne M, Dixit VM. In command of commensals. Nature. 2011;474:42-43.
63. Shanahan F. Probiotics in perspective. Gastroenterology. 2010;139:1808-1812.
64. Talley NJ, Abreu MT, Achkar J-P, etal. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol. 2011;106(Suppl 1):S2-S25.
65. Shanahan F. Molecular mechanisms of probiotic action: it's all in the strains! Gut. 2011;60:1026-1027.
66. Macho Fernandez E, Valenti V, Rockel C, etal. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut. 2011;60:1050-1059.
67. Steidler L, Hans W, Schotte L, etal. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science. 2000;289:1352-1355.
68. Braat H, Rottiers P, Hommes DW, etal. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol. 2006;4:754-759.
69. Vandenbroucke K, de Haard H, Beirnaert E, etal. Orally administered L. lactis secreting an anti-TNF nanobody demonstrate efficacy in chronic colitis. Mucosal Immunol. 2009;3:49-56.
70. Hamady ZZ, Scott N, Farrar MD, etal. Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus. Gut. 2010;59:461-469.
71. Hamady ZZ, Scott N, Farrar MD, etal. Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-β1 under the control of dietary xylan 1. Inflamm Bowel Dis. 2011;17:1925-1935.